Quote Originally Posted by Verik View Post
http://community.smallcapnetwork.com...p/mid/3/id/96/

been seeing some bearish talk in regards to BIEL. Talking about a target price of $.056. Not quite what I expected considering their financial audit is coming up and possible fda approval. Would this be a good example of just looking at the technical's rather than the whole picture (i.e. what is going on behind the numbers?)?
I've transitioned to doing that (checking actual data than hype) more often lately.. I figured BIEL would have had the run up affect but I am starting to realize the more something is pumped and expectations are high, the hype is already factored into the price. Today I sold off 2/3rds of my holding of BIEL, it may have the expected run up but the pumping of it has become a turn off for me. 8/10 stocks that I've followed that have been pumped end up not so great, others that kind of flew under the radar with good data typically had the big break outs.. of which pumpers usually jump on the banwagon after the real profits have been taken.

Not to say anything bad about BIEL but I've seen it numerous times this year. BIEL is now a spec play, MPTO has been added long term for the potential of a couple of its subsidiaries.